Literature DB >> 3699888

Serum and salivary antibody responses in rats orally immunized with Streptococcus mutans carbohydrate protein conjugate associated with liposomes.

D Wachsmann, J P Klein, M Scholler, J Ogier, F Ackermans, R M Frank.   

Abstract

In this study we describe the preparation of a Streptococcus mutans vaccine consisting of a purified polysaccharide antigen, derived from S. mutans OMZ175 serotype f, covalently coupled through reductive amination to a previously isolated 74,000-molecular-weight (74K) cell wall protein which interacts with saliva proteins (74K-SR). We also investigated the local and systemic immune response to the poly-74K-SR conjugate after oral administration of the conjugate associated with liposomes. Intragastric administration of liposome-associated poly-74K-SR conjugate in rats produced a local immunoglobulin A (IgA) response directed against the polysaccharide and the cell surface protein, whereas liposome-associated polysaccharide was unable to induce any detectable local IgA response. The antigenicity of the polysaccharide in the conjugate was not affected by the coupling reaction, while that of the cell surface protein was reduced. We showed that the immunogenicity of S. mutans polysaccharide could be improved by chemical coupling with a carrier cell surface protein. If such a conjugate were orally administered with liposomes it could constitute a potential vaccine against dental caries.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3699888      PMCID: PMC261014          DOI: 10.1128/iai.52.2.408-413.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Topics in the methodology of substitution reactions with agarose.

Authors:  I Parikh; S March; P Cuatercasas
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

2.  A simple method for coupling proteins to insoluble polysaccharides.

Authors:  C J Sanderson; D V Wilson
Journal:  Immunology       Date:  1971-06       Impact factor: 7.397

3.  Crossed immunoelectrophoresis.

Authors:  B Weeke
Journal:  Scand J Immunol Suppl       Date:  1973

4.  Inhibition of adsorption of Streptococcus mutans strains to saliva-treated hydroxyapatite by galactose and certain amines.

Authors:  R J Gibbons; J V Qureshi
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

Review 5.  Biology, immunology, and cariogenicity of Streptococcus mutans.

Authors:  S Hamada; H D Slade
Journal:  Microbiol Rev       Date:  1980-06

6.  Antigens of Streptococcus mutans: isolation of a serotype-specific and a cross-reactive antigen from walls of strain V-100 (serotype e).

Authors:  J F Wetherell; A S Bleiweis
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

7.  Glucan-binding proteins of Streptococcus mutans serotype c.

Authors:  R R Russell
Journal:  J Gen Microbiol       Date:  1979-05

8.  Chemical and immunological properties of the type f polysaccharide antigen of Streptococcus mutans.

Authors:  S Hamada; K Gill; H D Slade
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

9.  Identification and preliminary characterization of saliva-interacting surface antigens of Streptococcus mutans by immunoblotting, ligand blotting, and immunoprecipitation.

Authors:  J A Ogier; J P Klein; P Sommer; R M Frank
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

10.  Protection against group B meningococcal disease. II. Infection and resulting immunity in a guinea pig model.

Authors:  C E Frasch; J D Robbins
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

View more
  9 in total

1.  Flagellin-rPAc vaccine inhibits biofilm formation but not proliferation of S. mutans.

Authors:  Ying Sun; Yi Yang; Dihan Zhou; Yuan Cao; Jie Yu; Bali Zhao; Maohua Zhong; Yaoming Li; Jingyi Yang; Huimin Yan
Journal:  Hum Vaccin Immunother       Date:  2016-07-08       Impact factor: 3.452

2.  Structural studies of the serotype-f polysaccharide antigen from Streptococcus mutans OMZ175.

Authors:  R Linzer; M S Reddy; M J Levine
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

3.  Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit.

Authors:  M W Russell; H Y Wu
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

Review 4.  Recent advances in the development of a Streptococcus mutans vaccine.

Authors:  J P Klein; M Scholler
Journal:  Eur J Epidemiol       Date:  1988-12       Impact factor: 8.082

5.  Immunogenicity of polysaccharides conjugated to peptides containing T- and B-cell epitopes.

Authors:  E Lett; S Gangloff; M Zimmermann; D Wachsmann; J P Klein
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

6.  Antibody responses in the serum and respiratory tract of mice following oral vaccination with liposomes coated with filamentous hemagglutinin and pertussis toxoid.

Authors:  C A Guzman; G Molinari; M W Fountain; M Rohde; K N Timmis; M J Walker
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

7.  Mucosal immunogenicity of polysaccharides conjugated to a peptide or multiple-antigen peptide containing T- and B-cell epitopes.

Authors:  E Lett; C Klopfenstein; J P Klein; M Schöller; D Wachsmann
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

8.  Activation of human monocytes by Streptococcus mutans serotype f polysaccharide: immunoglobulin G Fc receptor expression and tumor necrosis factor and interleukin-1 production.

Authors:  S Benabdelmoumene; S Dumont; C Petit; P Poindron; D Wachsmann; J P Klein
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

9.  Second-generation Flagellin-rPAc Fusion Protein, KFD2-rPAc, Shows High Protective Efficacy against Dental Caries with Low Potential Side Effects.

Authors:  Jingyi Yang; Ying Sun; Rong Bao; Dihan Zhou; Yi Yang; Yuan Cao; Jie Yu; Bali Zhao; Yaoming Li; Huimin Yan; Maohua Zhong
Journal:  Sci Rep       Date:  2017-09-11       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.